Table 2. Correlations among study measures.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. RSA 36 months | |||||||||||||||
2. RSA 48 months | 49*** | — | |||||||||||||
3. RSA 60 months | 43*** | 46*** | — | ||||||||||||
4. RSA 72 months | 51 *** | 49*** | 49*** | — | |||||||||||
5. RSA-R 36 months | .26*** | .04 | −.03 | 17*** | — | ||||||||||
6. RSA-R 48 months | .004 | 34*** | .05 | .08 | .07 | — | |||||||||
7. RSA-R 60 months | −.01 | .06 | 27*** | 11** | .04 | 19*** | — | ||||||||
8. RSA-R 72 months | .004 | .01 | .09 | 23*** | .13** | .11* | 25*** | — | |||||||
9. Early adversity | −.003 | −.004 | .08* | 11** | −.09** | −.02 | .08* | .10** | — | ||||||
10. Prenatal substance exposure | .08* | .08* | .09* | 13*** | .09* | −.01 | .04 | .08* | 40*** | — | |||||
11. BD age 8/9 | −.03 | .01 | −.09* | .04 | −.08 | .01 | .03 | −.02 | 22*** | 11*** | — | ||||
12. BD age 11 | .03 | .05 | −.02 | .02 | −.01 | −.02 | .06 | −.04 | 25*** | .16*** | .58*** | — | |||
13. BD age 13/14 | −.02 | .05 | .05 | −.04 | −.05 | .05 | .05 | −.07 | 24*** | 20*** | 49*** | .62*** | — | ||
14. EF age 8/9 | −.03 | <.001 | .03 | .06 | −.04 | −.01 | −.07 | −.04 | 12*** | .04 | 17*** | 11*** | 11** | — | |
15. EFage 11 | .002 | 11** | .05 | .13** | −.09* | .02 | −.04 | −.03 | 15*** | .06 | .26*** | 19*** | 20*** | 49*** | — |
16. EF age 13/14 | −.02 | .06 | −.04 | .06 | −.08 | .06 | −.02 | −.11** | 12*** | .05 | 25*** | 19*** | 20*** | 44*** | 59*** |
Note: RSA, baseline respiratory sinus arrhythmia; RSA-R, RSA reactivity; BD, behavioral dysregulation; EF, executive dysfunction. Higher levels of RSA-R reflect greater RSA reactivity.
p < .05.
p < .01.
p < .001.